Engineered organoids for biomedical applications
(TIBI) Terasaki Institute for Biomedical Innovation ; Ghent University Hospital ; KTH Royal Institute of Technology ; (UNICAMP) Universidade Estadual de Campinas ; Amirkabir University of Technology ; California State University ; (UNESP) Universidade Estadual Paulista Júlio de Mesquita Filho ; University of Veterinary Medicine and Pharmacy in Kosice ; University of Victoria ; (USP) Universidade de São Paulo ; (POSTECH) Pohang University of Science and Technology
Appears in Collections:
As miniaturized and simplified stem cell-derived 3D organ-like structures, organoids are rapidly emerging as powerful tools for biomedical applications. With their potential for personalized therapeutic interventions and high-throughput drug screening, organoids have gained significant attention recently. In this review, we discuss the latest developments in engineering organoids and using materials engineering, biochemical modifications, and advanced manufacturing technologies to improve organoid culture and replicate vital anatomical structures and functions of human tissues. We then explore the diverse biomedical applications of organoids, including drug development and disease modeling, and highlight the tools and analytical techniques used to investigate organoids and their microenvironments. We also examine the latest clinical trials and patents related to organoids that show promise for future clinical translation. Finally, we discuss the challenges and future perspectives of using organoids to advance biomedical research and potentially transform personalized medicine.
Barros NR, Wang C, Maity S, Tanaka JL. Engineered organoids for biomedical applications. Advanced Drug Delivery Reviews. 2023, Dec; 203:115142. doi:10.1016/j.addr.2023.115142.
Link to cite this reference
The access to the publications deposited in this repository respects the licenses from journals and publishers.